13D/13G Filings - AEON Biopharma Inc. (AEON)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-07-28
07:55 am
Purchase
2023-07-2813DAEON Biopharma, Inc.
AEON
Daewoong Co. Ltd91,356
23.980%
91,356increase
(New Position)
Filing
History
2023-07-20
11:32 am
Unchanged
2023-07-1813GPriveterra Acquisition Corp.
PMGM
Saba Capital Management, L.P.0
0.000%
0
(Unchanged)
Filing
History
2023-06-12
4:42 pm
Sale
2023-05-3113GPriveterra Acquisition Corp.
PMGM
Glazer Capital, LLC59,166
2.950%
-168,378decrease
(-74.00%)
Filing
History
2023-03-10
4:33 pm
Purchase
2023-02-2813GPriveterra Acquisition Corp.
PMGM
Glazer Capital, LLC227,544
11.360%
227,544increase
(New Position)
Filing
History
2021-02-22
08:30 am
Purchase
2021-02-1113GPriveterra Acquisition Corp.
PMGMU
Empyrean Capital Partners LP1,400,000
5.100%
1,400,000increase
(New Position)
Filing
History
Goto Prev, 0, 1